Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
China's leading venture capital firm Qiming Venture Partners announced its recent signing of the United Nations-supported Principles for Responsible...
Qiming Venture Partners' portfolio company UBTech, a humanoid robot leader in China, successfully debuted on the Hong Kong Stock Exchange today. The...
Qiming Venture Partners' portfolio company Tuhu Car, China's leading one-stop car service platform, successfully listed on the Hong Kong Stock...
Qiming Venture Partners ("Qiming") today launched its first "Catalyst: Qiming Healthcare Summer Program 2023" for universities in Hong Kong,...
The 2023 Forbes Midas List, a prestigious industry list of world's best venture capital investors, was unveiled. Qiming Venture Partners Managing...
On April 27th Beijing time, Qiming Venture Partners' portfolio company MedSci Healthcare Holdings Limited("MedSci"), a leading physician digital...
On April 27th Beijing time, Qiming Venture Partners' portfolio company MedSci Healthcare Holdings Limited ("MedSci"), a leading physician digital...
On March 30, 2023, Apollomics Inc. ("Apollomics"), an innovative biopharmaceutical company and portfolio company of Qiming Venture Partners, listed...
LanzaTech NZ, Inc. ("LanzaTech"), an innovative leader in carbon capture and transformation and a Qiming Venture Partners portfolio company, listed...
On Feb 9 Beijing time, Hesai Technology ("Hesai"), a global leader in LiDAR technology and Qiming Venture Partners' portfolio company, began trading...
Qiming Venture Partners' portfolio company Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical stage global biopharmaceutical company focusing on...
On January 25, Beijing time, QuantaSing Group Limited, a Qiming Venture Partners portfolio company and China's leading online adult interest learning ...
Transwarp, a Qiming Venture Partners portfolio company and China's leading software developer of enterprise big data infrastructure, successfully...
Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.